caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1679550842

Kathy AlbainM.D.

Hematology-OncologyMaywood, ILI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Kathy Albain's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 19 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
LOYOLA UNIVERSITY MEDICAL CENTER2333,860
Mehdat Gabriel
Diagnostic Radiology · Maywood, IL
44146
Robert Wagner
Diagnostic Radiology · Maywood, IL
42162
Davide Bova
Diagnostic Radiology · Maywood, IL
2981
NPI 105348053328130
Konrad Lebioda
Diagnostic Radiology · Maywood, IL
2697
Nancy Budorick
Diagnostic Radiology · Maywood, IL
2576
BROOKS, CYNTHIA2354
Joseph Yacoub
Diagnostic Radiology · Maywood, IL
2266
NPI 10331969022074
Andrew Chiang
Diagnostic Radiology · Maywood, IL
1957
Claudia Perez
Surgical Oncology · Maywood, IL
1788
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
319
Unique beneficiaries
—
Total services
778
Distinct HCPCS
5
Medicare payment
$51K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 444 Hematology-Oncology providers in IL — below median (cohort median 1,266).
PRESCRIBING · PART D · 2024
Total Rx claims
268
Beneficiaries
—
Total drug cost
$421K
Distinct drugs
9
Brand share
13.8%
Top prescribed drugs
Letrozole80 claims
Exemestane59 claims
Anastrozole51 claims
Prochlorperazine Maleate16 claims
Osimertinib Mesylate13 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.